Detalhe da pesquisa
1.
Constitutional and acquired genetic variants in ARID5B in pediatric B-cell precursor acute lymphoblastic leukemia.
Genes Chromosomes Cancer
; 63(5): e23242, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38738968
2.
Clonal conversion of B lymphoid leukemia reveals cross-lineage transfer of malignant states.
Genes Dev
; 30(22): 2486-2499, 2016 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27913602
3.
Transcriptomics paving the way for improved diagnostics and precision medicine of acute leukemia.
Semin Cancer Biol
; 84: 40-49, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34606984
4.
Trailblazing precision medicine in Europe: A joint view by Genomic Medicine Sweden and the Centers for Personalized Medicine, ZPM, in Germany.
Semin Cancer Biol
; 84: 242-254, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34033893
5.
Novel precision medicine approaches and treatment strategies in hematological malignancies.
J Intern Med
; 294(4): 413-436, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37424223
6.
N-terminus DUX4-immunohistochemistry is a reliable methodology for the diagnosis of DUX4-fused B-lymphoblastic leukemia/lymphoma (N-terminus DUX4 IHC for DUX4-fused B-ALL).
Genes Chromosomes Cancer
; 61(8): 449-458, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35218117
7.
Targeting stem cells in myelodysplastic syndromes and acute myeloid leukemia.
J Intern Med
; 292(2): 262-277, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35822488
8.
Application of precision medicine in clinical routine in haematology-Challenges and opportunities.
J Intern Med
; 292(2): 243-261, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35599019
9.
13q12.2 deletions in acute lymphoblastic leukemia lead to upregulation of FLT3 through enhancer hijacking.
Blood
; 136(8): 946-956, 2020 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32384149
10.
PAX5 is part of a functional transcription factor network targeted in lymphoid leukemia.
PLoS Genet
; 15(8): e1008280, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31381561
11.
Single-cell sequencing in translational cancer research and challenges to meet clinical diagnostic needs.
Genes Chromosomes Cancer
; 60(7): 504-524, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33611828
12.
Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based study.
Genes Chromosomes Cancer
; 60(6): 426-433, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33433047
13.
Combinatorial molecule screening identified a novel diterpene and the BET inhibitor CPI-203 as differentiation inducers of primary acute myeloid leukemia cells.
Haematologica
; 106(10): 2566-2577, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32855276
14.
Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases.
Proc Natl Acad Sci U S A
; 115(50): E11711-E11720, 2018 12 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30487223
15.
A high-content cytokine screen identifies myostatin propeptide as a positive regulator of primitive chronic myeloid leukemia cells.
Haematologica
; 105(8): 2095-2104, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582541
16.
Genetic profiling of a chondroblastoma-like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1-FGFR1 gene fusion.
Genes Chromosomes Cancer
; 58(10): 731-736, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31066955
17.
Why B(-)other? About the gap of unknowns in ALL.
Blood
; 139(24): 3455-3457, 2022 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35708724
18.
New oncogenic subtypes in pediatric B-cell precursor acute lymphoblastic leukemia.
Blood
; 130(12): 1395-1401, 2017 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28778863
19.
Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms.
Blood
; 129(16): 2266-2279, 2017 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28202457
20.
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells.
Haematologica
; 104(10): 2006-2016, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30819903